“Advanced therapies represent an important option in the treatment of plaque psoriasis, but as a physician, it’s critically important to continually assess if patients are having an optimal ...

Discover a study that investigates spesolimab, a monoclonal antibody that has been approved as the first GPP-specific therapy ...

In people with light skin tones, plaque psoriasis is characterized by raised ... I got ghosted for a reality TV dating show spot, and my confidence tanked. About five years ago, I was trying ...

Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

With dandruff, you will notice loose flakes of skin on your head and in your hair, but you are not likely to find a singular spot of flaking. If you have psoriasis, the flakes will form a plaque.

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Bristol Myers Squibb has released new 5-year results from the long-term trial evaluating Sotyktu for the treatment of adults with moderate to severe plaque psoriasis, according to a press release.

The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis, marking the company’s entry into immuno-dermatology ...